Industries
Algae Biotechnology
Algae biotechnology harnesses the photosynthetic efficiency and metabolic versatility of microalgae and macroalgae to produce high-value compounds—lipids, pigments, proteins, polysaccharides, and recombinant biologics—under closed or open cultivation systems. Companies such as Corbion, Qualitas Health, AlgaEnergy, and Neste have industrialized algal oil production for omega-3 nutraceuticals, aquaculture feed, and biofuel blending, while academic groups exploit Chlamydomonas reinhardtii and Nannochloropsis as model organisms for photosynthesis research. Researchers procure flatpanel photobioreactors, LED illumination arrays, nutrient dosing systems, centrifugal harvesting equipment, and downstream extraction kits for carotenoids and EPA/DHA. The sector intersects aquaculture nutrition, carbon-capture mandates, and circular-bioeconomy policies, attracting both public research grants and corporate venture investment. Sell to Scientists CLI surfaces relevant reagent suppliers, photobioreactor vendors, and contract cultivation services for algal research teams building sustainable bioprocesses.
Details
- Companies
- CorbionQualitas Health (iwi)TerraViaNesteAlgaEnergySynthetic GenomicsAlgenuity
- Market Size
- $1.7 billion (2024), projected $5.1 billion by 2030 at 18.9% CAGR
- Target Researchers
- Algal biologists, bioprocess engineers, environmental biotechnologists, feed and food scientists, and sustainability researchers focused on photosynthetic production platforms.
- Use Cases
- Omega-3 fatty acid and astaxanthin production for nutraceuticalsBiofuel and biorefinery feedstock productionCO2 bioremediation and carbon fixationHigh-protein algal biomass for aquaculture and animal feedPharmaceutical recombinant protein expression in microalgaeAlgal biofilm sensors for environmental monitoringPhotobioreactor scale-up for industrial fermentation